Stay updated on Lumasiran in Primary Hyperoxaluria Type 1 Infants/Young Children Clinical Trial
Sign up to get notified when there's something new on the Lumasiran in Primary Hyperoxaluria Type 1 Infants/Young Children Clinical Trial page.

Latest updates to the Lumasiran in Primary Hyperoxaluria Type 1 Infants/Young Children Clinical Trial page
- Check2 days agoChange DetectedRevision: v3.5.0 is now shown, replacing the previous Revision: v3.4.3 entry.SummaryDifference0.1%

- Check9 days agoNo Change Detected
- Check16 days agoChange DetectedFooter revision updated from v3.4.2 to v3.4.3.SummaryDifference0.1%

- Check23 days agoNo Change Detected
- Check37 days agoChange DetectedThe page revision was updated from v3.4.1 to v3.4.2; no changes to study content or navigation were detected. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.1%

- Check45 days agoChange DetectedRevision label updated from v3.4.0 to v3.4.1 on the page; no changes to study information or layout. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.1%

- Check67 days agoChange DetectedThe page revision indicator updated from v3.3.3 to v3.3.4, which is a metadata update and does not affect study content or user actions. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.1%

- Check88 days agoChange DetectedThe page footer now lists Revision: v3.3.3, and the items HHS Vulnerability Disclosure and Revision: v3.3.2 have been removed. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.1%

Stay in the know with updates to Lumasiran in Primary Hyperoxaluria Type 1 Infants/Young Children Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Lumasiran in Primary Hyperoxaluria Type 1 Infants/Young Children Clinical Trial page.